scienceliberal

Genetics of ADHD: What Doctors Need to Know

Tuesday, June 16, 2026
ADHD is a common brain condition that starts early and can last into adulthood. About one in twenty kids shows symptoms, and a few percent of adults still struggle with it. Families often ask doctors about genes, so clinicians must be up‑to‑date on the science. \n\nResearch shows that genetics play a big role—around 70% of the risk comes from inherited DNA. This is similar to other major mental health disorders. \n\nLarge studies called genome‑wide association studies (GWAS) have found that many small genetic changes add up to increase ADHD risk. No single gene is the culprit; instead, thousands of common variants each have a tiny effect. \n\nRare genetic changes, known as copy number variants (CNVs), appear more often in people with ADHD than in those without. Some of these CNVs are also seen in autism, hinting at shared biological pathways. \n\nThe genes linked to ADHD mainly affect brain development and the frontal areas that control attention and impulse control. These genetic risks also relate to thinking skills, a tendency for risky behavior, and other health problems.
\n\nThe environment matters too. How genes interact with life experiences can change how ADHD shows up and how it progresses. \n\nWhen it comes to medication, testing a person’s CYP2D6 gene can help doctors decide the right dose of atomoxetine. However, routine genetic testing to pick a stimulant medication is not recommended at this time. \n\nBecause no single test can diagnose ADHD, doctors should focus on how the symptoms affect daily life, look at family history, and check for other conditions. Education should highlight that while genes matter, lifestyle choices and support can make a big difference. \n\nIn short, genetics confirm that ADHD is rooted in brain development and shares similarities with other childhood disorders. Doctors can use this knowledge to guide conversations and watch for related risks, but they should not rely on genetic tests beyond specific medication guidance. \n\n

Actions